Health
In vitro testing suggests effective novel drug combinations for SARS-CoV-2 – News-Medical.Net
A recent study published on the preprint server bioRxiv* in September 2020 shows the value of drug combinations to enhance the therapeutic and preventive efficacy of such repositioned drugs in standard antiviral therapy.
Every year, emerging and re-emerging viruses, such as SARS-CoV-2, MERS-CoV, Zika virus, Ebola virus, influenza A virus, and Rift Valley fever virus surface from natural reservoirs to infect, disable, and kill people. Today, the number of people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to rise, with 30.9 million recorded infections and a global death toll nearing 1 million.
The high expense and delay associated with drug development is a significant de…
-
General11 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General14 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
Noosa News19 hours agoWave of cruises headed for Sunshine Coast this summer
-
General22 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’